XML 22 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:      
Net income $ 158,611 $ 220,704 $ 122,021
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 12,198 13,360 13,976
Stock-based compensation expense 7,275 8,478 12,167
Inventory impairments and abandonments 641 2,963 853
Deferred and other income tax expense 23,936 53,267 21,501
Loss (gain) on disposal of fixed assets 1,113 (332) (392)
Change in allowance for doubtful accounts 0 (6) (68)
Loss (gain) on extinguishment of debt, net 546 (309) 2,025
Changes in operating assets and liabilities:      
Increase in accounts receivable (9,708) (10,199) (5,800)
Decrease in income tax receivable 9,987 0 460
Increase in inventory (14,749) (231,445) (147,511)
Increase in other assets (2,784) (2,761) (2,384)
Increase in trade accounts payable 10,615 10,250 1,199
(Decrease) increase in other liabilities (19,624) 17,104 13,609
Net cash provided by operating activities 178,057 81,074 31,656
Cash flows from investing activities:      
Capital expenditures (20,334) (15,048) (14,645)
Proceeds from sale of fixed assets 445 339 456
Purchases of investment securities (9,779) 0 0
Other (2) 0 0
Net cash used in investing activities (29,670) (14,709) (14,189)
Cash flows from financing activities:      
Repayment of debt (8,998) (73,900) (82,476)
Repayment of borrowings from credit facility 0 (195,000) 0
Borrowings from credit facility 0 195,000 0
Debt issuance costs (2,575) 0 (901)
Repurchase of common stock 0 (8,154) 0
Tax payments for stock-based compensation awards (2,615) (6,631) (3,044)
Stock option exercises 262 5 569
Net cash used in financing activities (13,926) (88,680) (85,852)
Net increase (decrease) in cash, cash equivalents, and restricted cash 134,461 (22,315) (68,385)
Cash, cash equivalents, and restricted cash at beginning of period 251,828 274,143 342,528
Cash, cash equivalents, and restricted cash at end of period $ 386,289 $ 251,828 $ 274,143